Keyword: Sterling Pharma

Research & Innovation

Expert Statement: Mark Muldowney, Sterling Pharma Solutions

26.09.2022 -

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this...


Sterling Pharma Solutions to Expand US Plant

31.01.2022 -

Sterling Pharma Solutions, a globally active CDMO based in Birmingham, England, has kicked off a $2.1 million expansion project to increase chemical and analytical...


Sterling Pharma Invests Further at Dudley

24.11.2021 -

UK CDMO Sterling Pharma Solution has announced the next phase of a multi-year investment at its site in Dudley. The £10m project will include new process development...


Sterling Pharma Buys ADC Bio

15.04.2021 -

UK CDMO Sterling Pharma Solutions has acquired compatriot firm ADC Biotechnology, a specialist in antibody drug conjugates (ADCs). The acquisition follows Sterling’s...


Sterling Pharma Partners ADC Biotechnology

04.12.2020 -

CDMO Sterling Pharma Solutions has formed a strategic partnership with ADC Biotechnology, a UK-based specialist in the discovery, development and manufacture of antibody...


Sterling Pharma Expands UK Pilot Plant

06.06.2019 - Sterling Pharma Solutions, a UK-based contract development and manufacturing organization (CDMO), has announced that its pilot plant expansion at Cramlington is now operational...